Myomo MYO

Myomo reports record revenue of $12.3 million for Q3 2026

Myomo (MYO) filed an 8-K with the SEC on Nov 9, 2026, 4:10 pm ET. Source: the filing on SEC EDGAR.

Item 2.02 Reports results

Form
8-K
Filed
Importance
Major
  1. Revenue increased 22% year over year to $12.3 million
  2. 54% of revenue came from recurring patient sources
  3. Adjusted EBITDA was breakeven for the quarter
  4. Full-year revenue guidance narrowed to $46-47 million

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Get an email when Myomo files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.